We saw the same pattern repeatedly: promising medical device companies failing not because of bad technology, but because of blind spots that specialized expertise could have identified early.
Investors were relying on generalist consultants who missed critical clinical adoption risks. Founders were getting regulatory advice that looked good on paper but fell apart in practice. The gap between technical due diligence and real-world medical device success was costing everyone.
Vantage was built to close that gap. By combining a physician's understanding of clinical reality with an engineer's rigor on technical execution, we provide the kind of insight that actually predicts outcomes.